Barbasol TV Ads Planned After 10-Year Hiatus - Perio Exec
This article was originally published in The Rose Sheet
Executive Summary
Barbasol Shave Cream's market share is projected to double within two years due to enhanced marketing efforts, Perio President and CEO Tom Murray predicted.
You may also be interested in...
Barbasol sale
Pfizer's men's shaving business acquired by Dublin, Ohio-based Perio to complement its existing portfolio, which includes Hers shave creams and Nudit depilatory products. With 2000 sales of $18 mil., 11-SKU Barbasol line is widely-distributed, well-recognized brand with "rich heritage" and low price points, Perio says. Divestiture is not indicative of effort to jettison or downsize shaving business, Pfizer maintains. Pharmaceutical firm also markets Schick brand; Pfizer shaving care category accounts for sales of $790 mil., according to the firm
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle